Reduction of circulating innate lymphoid cell progenitors results in impaired cytokine production by innate lymphoid cells in patients with lupus nephritis

[1]  Nir Hacohen,et al.  The immune cell landscape in kidneys of patients with lupus nephritis , 2019, Nature Immunology.

[2]  B. Walker,et al.  Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression. , 2016, Immunity.

[3]  B. Stockinger,et al.  Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis , 2018, Immunity.

[4]  T. Schumacher,et al.  T Cell Dysfunction in Cancer. , 2018, Cancer cell.

[5]  I. Amit,et al.  Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation , 2017, Cell.

[6]  H. Spits,et al.  Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases , 2017, Nature Reviews Rheumatology.

[7]  F. Wong,et al.  Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen‐reactive T cell responses: position statement of the T‐Cell Workshop Committee of the Immunology of Diabetes Society , 2011, Clinical and experimental immunology.

[8]  Zheng Zhang,et al.  Plasmacytoid dendritic cells promote HIV-1-induced group 3 innate lymphoid cell depletion. , 2015, The Journal of clinical investigation.

[9]  J. James,et al.  Haematological manifestations of lupus , 2015, Lupus Science & Medicine.

[10]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[11]  Marjolein J. W. de Bruijn,et al.  KLRG1 and NKp46 discriminate subpopulations of human CD117+CRTH2− ILCs biased toward ILC2 or ILC3 , 2019, The Journal of experimental medicine.

[12]  A. Deshpande,et al.  Group 2 Innate Lymphoid Cells Are Redundant in Experimental Renal Ischemia-Reperfusion Injury , 2019, Front. Immunol..

[13]  B. Hahn Antibodies to DNA. , 1998, The New England journal of medicine.

[14]  W. Fokkens,et al.  IL-1β, IL-23, and TGF-β drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation , 2019, Nature Communications.

[15]  G. Tsokos,et al.  Systemic lupus erythematosus. , 2011, The New England journal of medicine.

[16]  G. Sireci,et al.  Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis , 2015, Annals of the rheumatic diseases.

[17]  L. Vaas,et al.  CD4(+) T cells in patients with chronic inflammatory rheumatic disorders show distinct levels of exhaustion. , 2016, The Journal of allergy and clinical immunology.

[18]  R. Locksley,et al.  Innate Lymphoid Cells: 10 Years On , 2018, Cell.

[19]  D. Adams,et al.  Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score , 2017, PloS one.

[20]  L. L. van den Hoogen,et al.  Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome. , 2019, Rheumatology.

[21]  Michael A. Smith,et al.  SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid Lupus , 2019, Scientific Reports.

[22]  S. Koyasu,et al.  Plastic Heterogeneity of Innate Lymphoid Cells in Cancer. , 2017, Trends in cancer.

[23]  U. Panzer,et al.  IL-33-Mediated Expansion of Type 2 Innate Lymphoid Cells Protects from Progressive Glomerulosclerosis. , 2017, Journal of the American Society of Nephrology : JASN.

[24]  M. Caligiuri,et al.  A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell Subsets. , 2016, Immunity.

[25]  A. Lackner,et al.  Type 3 innate lymphoid cell depletion is mediated by TLRs in lymphoid tissues of simian immunodeficiency virus‐infected macaques , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  Gerald McGwin,et al.  Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. , 2012, Arthritis and rheumatism.

[27]  M. Neurath,et al.  Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells , 2017, Nature Medicine.

[28]  B. Tsao,et al.  Genetic susceptibility to systemic lupus erythematosus in the genomic era , 2010, Nature Reviews Rheumatology.

[29]  T. Cupedo,et al.  Review: Innate Lymphoid Cells: Sparking Inflammatory Rheumatic Disease? , 2017, Arthritis & rheumatology.

[30]  G. Schett,et al.  Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis , 2015, Annals of the rheumatic diseases.

[31]  Mengyuan Li,et al.  Innate lymphoid cell disturbance with increase in ILC1 in systemic lupus erythematosus. , 2019, Clinical immunology.

[32]  M. Crow Type I Interferon in the Pathogenesis of Lupus , 2014, The Journal of Immunology.

[33]  L. Boon,et al.  PD-1 Is Involved in the Dysregulation of Type 2 Innate Lymphoid Cells in a Murine Model of Obesity. , 2018, Cell reports.

[34]  B. Rovin,et al.  A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis. , 2016, Kidney international.

[35]  U. Panzer,et al.  T cell‐derived IFN‐γ downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus , 2018, European journal of immunology.

[36]  D. Harris,et al.  Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury. , 2018, Journal of the American Society of Nephrology : JASN.

[37]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[38]  Navin Rustagi,et al.  CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway , 2018, Immunity.

[39]  J. Brenchley,et al.  Hallmarks of primate lentiviral immunodeficiency infection recapitulate loss of innate lymphoid cells , 2018, Nature Communications.

[40]  G. Eberl,et al.  The brave new world of innate lymphoid cells , 2014, Nature Immunology.

[41]  Matthias Schneider,et al.  The new targeted therapy in systemic lupus erythematosus: Is the glass half-full or half-empty? , 2017, Autoimmunity reviews.

[42]  A. Kamphorst,et al.  CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions. , 2018, Annual review of medicine.

[43]  B. Rovin,et al.  Update on Lupus Nephritis. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[44]  Shuming Sun,et al.  IL-25 Elicits Innate Lymphoid Cells and Multipotent Progenitor Type 2 Cells That Reduce Renal Ischemic/Reperfusion Injury. , 2015, Journal of the American Society of Nephrology : JASN.

[45]  Samuel J. Taylor,et al.  PD-1 regulates KLRG1+ group 2 innate lymphoid cells , 2017, The Journal of experimental medicine.

[46]  J. Yazdany,et al.  Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review. , 2017, Autoimmunity reviews.

[47]  J. Goust,et al.  Systemic lupus erythematosus. , 1976, Immunology series.

[48]  L. Boon,et al.  CD62L Is a Functional and Phenotypic Marker for Circulating Innate Lymphoid Cell Precursors , 2018, The Journal of Immunology.